Philips announced FDA 510(k) clearance of its next-generation reusable Philips SpO₂ clip sensor.
The enhanced sensor incorporates internal optical refinements to further improve signal quality and measurement consistency, supporting reliable SpO₂ measurements across diverse patient populations and clinical conditions.
The FDA-cleared reusable clip sensor is backed by Philips' pulse oximetry validation program, which evaluates performance across diverse patient populations — including varying skin tones — and a range of physiological and clinical conditions. Philips' validation practices align with evolving FDA recommendations and applicable international standards, including those established by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC).
Philips continues to collaborate with clinicians, researchers, regulators and standards organizations to strengthen the science behind pulse oximetry and support the continued evolution of validation practices. Through ongoing investment in research, innovation and clinical evidence, Philips is helping advance pulse oximetry that clinicians can trust to perform consistently across diverse skin tones and patient physiological conditions.
The FDA-cleared reusable Philips SpO₂ clip sensor will become available in select markets across the globe later this year.
